Question: can xeljanz cause blood clots?
Answer: EMA has concluded that Xeljanz (tofacitinib) could increase the risk of blood clots in the lungs and in deep veins in patients who are already at high risk. As a result, the Agency is recommending that Xeljanz should be used with caution in all patients at high risk of blood clots.